安全统计学

安全统计学安全统计学
  1. 两组临床有效性和安全性无统计学显著性差异(P>0.05)。

    There was no statistically significant differences in clinical efficacy and incidence of adverse reaction between the 2 groups ( P > 0.05 ) .

  2. 观察两组患者的临床疗效,治疗前后日常生活能力的评测及安全性比较,统计学分析及评价。

    The clinical efficacy were observed before and after treatment of daily living and safety comparative evaluation , statistical analysis and evaluation .

  3. 对安全性指标进行统计学处理,治疗组未发现明显药物不良反应,提示经验方治疗瘀血痹阻型AS安全可靠。

    On the safety index for statistical analysis , the treatment group without obvious adverse drug reactions , suggesting that experience Blockage Treatment of blood stasis type AS safe and reliable .